Home › Malattia di Crohn › Rhode Island › Providence
Studi clinici su Malattia di Crohn a Providence, RI
12 studi su Malattia di Crohn cercano partecipanti presso sedi a Providence e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
In reclutamentoFase 3
- University Gastroenterology - Providence - West River Street ( Site 5057), Providence
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
In reclutamentoFase 2
- University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
In reclutamentoFase 4
- University Gastroenterology, Providence
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 2/3
- University Gastroenterology, Providence
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 2
- University Gastroenterology Providence, Providence
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
In reclutamentoFase 3
- University Gastroenterology, Providence
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- University Gastroenterology-Site Number: 8400103, Providence
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- University Gastroenterology - GI Alliance-Site Number: 8400103, Providence
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
In reclutamentoFase 4
- University Gastroenterology, Providence
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
In reclutamento
- Gastroenterology Associates, Providence
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
In reclutamentoFase 4
- Rhode Island Hospital, Providence
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
In reclutamentoFase 2
- Mirador Therapeutics Selected Site, Providence
Studi su Malattia di Crohn in altre città
- New York City, NY35 studi
- Cleveland, OH19 studi
- St. Louis, MO19 studi
- Boston, MA19 studi
- Miami, FL19 studi
- Orlando, FL17 studi
- Houston, TX17 studi
- Atlanta, GA17 studi
- Tyler, TX16 studi
- San Diego, CA15 studi
- San Antonio, TX15 studi
- Los Angeles, CA15 studi
Altri studi a Providence
- Cancro ovarico15 studi
- Cancro dell'endometrio14 studi
- Obesità14 studi
- Cancro del polmone non a piccole cellule12 studi
- Cancro (tutti i tipi)12 studi
- Colite ulcerosa11 studi
- Cancro al seno11 studi
- Leucemia mieloide acuta10 studi
- Cancro metastatico9 studi
- Sovrappeso9 studi
- Morbo di Alzheimer8 studi
- Disturbo da uso di alcol (AUD)8 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.